𝔖 Bobbio Scriptorium
✦   LIBER   ✦

4507 ORAL Axitinib (AG-013736; AG) in patients (pts) with metastatic clear cell renal cell cancer (RCC) refractory to sorafenib

✍ Scribed by Rini, B.; Wilding, G.; Hudes, G.; Stadler, W.M.; Kim, S.; Tarazi, J.; Bycott, P.; Liau, K.; Dutcher, J.


Book ID
123486728
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
59 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.